Company: BBVXF
Filing Date: 2025-08-12
Form Type: DRS
Source: 0000950123-25-007520
Chunk: 7

Company: BANCO BILBAO VIZCAYA ARGENTARIA, S.A.
Filing Date: 2025-08-12
Form: DRS
Chunk 7
---
 made available) to all holders of Banco Sabadell shares.

The exchange offer is being made on the terms and subject to the conditions set forth in this offer to exchange/prospectus under
“The Exchange Offer” beginning on page 122.

THE EXCHANGE OFFERWILL EXPIRE AT 5:59:59 P.M. EASTERN TIME (11:59:59 P.M. CENTRAL EUROPEAN TIME) (THE “EXPIRATION TIME”) ON , 2025 (AS SUCH DATE MAY BE EXTENDED, THE “EXPIRATION DATE”), UNLESS THE EXCHANGE OFFER IS EXTENDED.

BBVA shares are listed on the Spanish Stock Exchanges under the symbol “BBVA”. BBVA shares are also listed on the London Stock
Exchange (“LSE”) under the symbol “BVA” and the Mexican Stock Exchange under the symbol “BBVA”. BBVA’s American Depositary Shares (“BBVA ADSs”) are listed on the New York Stock Exchange (“NYSE”)
under the symbol “BBVA”. Each BBVA ADS represents the right to receive one BBVA share. Banco Sabadell shares are listed on the Spanish Stock Exchanges under the symbol “SAB”. On August 4, 2025, the closing price of the BBVA
shares listed on the Spanish Stock Exchanges was €14.80 (equivalent to U.S.$17.12 based on the exchange rate as published by the European Central Bank (“ECB”) on such date). On August 4, 2025, the closing price of the Banco Sabadell
shares listed on the Spanish Stock Exchanges was €3.19 (equivalent to U.S.$3.68 based on the exchange rate as published by the ECB on such date).

On July 5, 2024, BBVA’s extraordinary general shareholders’ meeting approved to authorize the increase of BBVA’s share
capital in an amount of up to €551,906,524.05 through the issuance of up to 1,126,339,845 newly-issued BBVA shares to be offered to the holders of Banco Sabadell shares pursuant to the exchange offer, with shareholders representing 70.75% of
the outstanding BBVA shares present at such meeting and 96.01% of such shareholders voting in favor.

See “Risk Factors” in this offer to exchange/prospectus beginning on page 41 for a discussion of various risk factors that you should consider before deciding whether or not to tender